GUJTHEM Stock View

Gujarat Themis Biosyn Ltd


icon 16.35 | 2.20
Market Cap ₹( Cr.)
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
Proj. Revenue ( Cr.)

Stock View

Last Updated On.

The average score for Gujarat Themis Biosyn Ltd stands at 6 against 3, three months back.

Gujarat Themis Biosyn Limited is engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company operates through manufacturing of bulk drugs segment. The Company's products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin. The Company's research and development division focuses on developing fermentation cultures. The Company's plant is located at Valsad, Gujarat.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data

50 DMA(₹)
100 DMA(₹)
200 DMA(₹)
52 Weeks Range
376.10     921.05